Legis Daily

Federal Clarity for Kratom Consumers Act

USA117th CongressHR-9634| House 
| Updated: 12/20/2022
Mark Pocan

Mark Pocan

Democratic Representative

Wisconsin

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Federal Clarity for Kratom Consumers Act This bill requires the Food and Drug Administration (FDA) to hold a hearing and establish a task force on the health and safety of products with kratom (an herbal substance that produces opioid- and stimulant-like effects). It also prohibits the FDA from regulating kratom products in a manner that is more restrictive as compared to regulations for food, dietary supplements, or dietary ingredients.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Dec 20, 2022

Latest Companion Bill Action

S 117-5316
Introduced in Senate
Dec 20, 2022
Introduced in House
Dec 20, 2022
Referred to the House Committee on Energy and Commerce.
  • December 20, 2022

    Latest Companion Bill Action

    S 117-5316
    Introduced in Senate


  • December 20, 2022
    Introduced in House


  • December 20, 2022
    Referred to the House Committee on Energy and Commerce.

Health

Related Bills

  • S 117-5316: Federal Clarity for Kratom Consumers Act
Administrative law and regulatory proceduresAdvisory bodiesCongressional oversightConsumer affairsDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationExecutive agency funding and structureFood and Drug Administration (FDA)Food supply, safety, and labelingGovernment information and archivesResearch administration and funding

Federal Clarity for Kratom Consumers Act

USA117th CongressHR-9634| House 
| Updated: 12/20/2022
Federal Clarity for Kratom Consumers Act This bill requires the Food and Drug Administration (FDA) to hold a hearing and establish a task force on the health and safety of products with kratom (an herbal substance that produces opioid- and stimulant-like effects). It also prohibits the FDA from regulating kratom products in a manner that is more restrictive as compared to regulations for food, dietary supplements, or dietary ingredients.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Dec 20, 2022

Latest Companion Bill Action

S 117-5316
Introduced in Senate
Dec 20, 2022
Introduced in House
Dec 20, 2022
Referred to the House Committee on Energy and Commerce.
  • December 20, 2022

    Latest Companion Bill Action

    S 117-5316
    Introduced in Senate


  • December 20, 2022
    Introduced in House


  • December 20, 2022
    Referred to the House Committee on Energy and Commerce.
Mark Pocan

Mark Pocan

Democratic Representative

Wisconsin

Energy and Commerce Committee

Health

Related Bills

  • S 117-5316: Federal Clarity for Kratom Consumers Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresAdvisory bodiesCongressional oversightConsumer affairsDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationExecutive agency funding and structureFood and Drug Administration (FDA)Food supply, safety, and labelingGovernment information and archivesResearch administration and funding